We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients from Bulgaria for healthcare practitioners.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Imposing safeguard measures for imports of certain steel products.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Offenders in Wales with low-level mental health issues will be required to address them as part of a government scheme to tackle a major root cause of crime.
Ofqual's formal legal list of Regulatory Documents (documents containing additional rules and guidance for regulated qualifications).
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
Information on chloroform (also known as trichloromethane or methyl trichloride), for use in responding to chemical incidents.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
Minister for Crime, Policing and Fire promotes the UK’s balanced approach towards tackling drug use, with a focus on the challenge of synthetic opioids.
Sets out legal text on the manufacture, authorisation, marketing, distribution and post-authorisation surveillance of veterinary medicines.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
The characteristics, diagnosis and epidemiology of LGV.
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
This leaflet outlines the lessons learnt from reports received on adverse incidents around dialysis.
A Global Support Organisation location guide.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices and a reminder of a recent MHRA National Patient Safety Alert to highlight the potential risk of underdosing with calcium gluconate in severe hyperkalaemia....
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.